Therapeutic concepts in succinate semialdehyde dehydrogenase (SSADH; ALDH5a1) deficiency (γ-hydroxybutyric aciduria). Hypotheses evolved from 25 years of patient evaluation, studies in Aldh5a1−/− mice and characterization of γ-hydroxybutyric acid pharmacology

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Inherited Metabolic Disease

• Publication date

  2007-04-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10545-007-0574-2PMID 17457693
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolism of [U-14C]-4-hydroxybutyric acid to intermediates of the tricarboxylic acid cycle in extracts of rat liver and kidney mitochondria

  2010cited by this paper
• Low-carb diets, fasting and euphoria: Is there a link between ketosis and γ-hydroxybutyrate (GHB)?

  2007influential reference
• Diagnostic challenges in a severely delayed infant with hypersomnolence, failure to thrive and arteriopathy: A unique case of γ‐hydroxybutyric aciduria and Williams syndrome

  2007cited by this paper
• Low-carb diets, fasting and euphoria: Is there a link between ketosis and gamma-hydroxybutyrate (GHB)?

  2007influential reference
• Gamma‐hydroxybutyrate – a drug of abuse

  2006cited by this paper
• Succinate semialdehyde dehydrogenase deficiency does not down-regulate gamma-hydroxybutyric acid binding sites in the mouse brain.

  2006cited by this paper
• Paediatric movement disorders: Progress in understanding

  2006cited by this paper
• Status epilepticus in mice deficient for succinate semialdehyde dehydrogenase: GABAA receptor–mediated mechanisms

  2006cited by this paper
• Expression profiling reveals multiple myelin alterations in murine succinate semialdehyde dehydrogenase deficiency

  2006influential reference
• Metabolism of gamma-hydroxybutyrate to d-2-hydroxyglutarate in mammals: further evidence for d-2-hydroxyglutarate transhydrogenase.

  2006cited by this paper
• Crystal structure of mouse succinic semialdehyde reductase AKR7A5: structural basis for substrate specificity.

  2006cited by this paper
• Effects of uridine in models of epileptogenesis and seizures.

  2006cited by this paper
• D-2-hydroxyglutaric aciduria in three patients with proven SSADH deficiency: genetic coincidence or a related biochemical epiphenomenon?

  2006cited by this paper
• Acetoacetate protects neuronal cells from oxidative glutamate toxicity

  2006cited by this paper
• Neurotransmitter transporters and their impact on the development of psychopharmacology

  2006cited by this paper
• Taurine rescues hippocampal long-term potentiation from ammonia-induced impairment.

  2006cited by this paper
• γ-Hydroxybutyrate induces cyclic AMP-responsive element-binding protein phosphorylation in mouse hippocampus: An involvement of GABAB receptors and cAMP-dependent protein kinase activation

  2006cited by this paper
• Identification of the gene encoding hydroxyacid‐oxoacid transhydrogenase, an enzyme that metabolizes 4‐hydroxybutyrate

  2006influential reference
• Efficacy of the Ketogenic Diet as a Treatment Option for Epilepsy: Meta-analysis

  2006cited by this paper
• The ketogenic diet: from molecular mechanisms to clinical effects.

  2006cited by this paper
• Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms.

  2006cited by this paper
• The Onset of Brain Injury and Neurodegeneration Triggers the Synthesis of Docosanoid Neuroprotective Signaling

  2006cited by this paper
• SSADH Variation in Primates: Intra- and Interspecific Data on a Gene with a Potential Role in Human Cognitive Functions

  2006cited by this paper
• Clinical, cytogenetic and molecular characterization of a patient with combined succinic semialdehyde dehydrogenase deficiency and incomplete WAGR syndrome with obesity.

  2006cited by this paper
• Taurine elevates dopamine levels in the rat nucleus accumbens; antagonism by strychnine

  2006cited by this paper
• Increased guanidino species in murine and human succinate semialdehyde dehydrogenase (SSADH) deficiency.

  2006cited by this paper
• Increased striatal dopamine synthesis is associated with decreased tissue levels of tyrosine.

  2006cited by this paper
• GABAB receptor antagonism abolishes the learning impairments in rats with chronic atypical absence seizures.

  2006cited by this paper
• Succinic semialdehyde dehydrogenase deficiency: GABAB receptor-mediated function.

  2006cited by this paper
• A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis

  2006cited by this paper
• Ambient GABA Constrains the Strength of GABAergic Synapses at Cajal-Retzius Cells in the Developing Visual Cortex

  2006cited by this paper
• gamma-Hydroxybutyrate induces cyclic AMP-responsive element-binding protein phosphorylation in mouse hippocampus: an involvement of GABA(B) receptors and cAMP-dependent protein kinase activation.

  2006cited by this paper
• Glutamine in the mechanism of ammonia-induced astrocyte swelling.

  2006cited by this paper
• Chronic intragastric administration of gamma-butyrolactone produces physical dependence in baboons

  2006cited by this paper
• Streptozotocin-induced diabetes differentially modifies haloperidol- and gamma-hydroxybutyric acid (GHB)-induced catalepsy.

  2005cited by this paper
• Kinetic characterization of human hydroxyacid–oxoacid transhydrogenase: Relevance toD-2-hydroxyglutaric and γ-hydroxybutyric acidurias

  2005cited by this paper
• Resuscitative Effect of a γ-Aminobutyric Acid B Receptor Antagonist on γ-Hydroxybutyric Acid Mortality in Mice

  2005cited by this paper
• Involvement of gamma-hydroxybutyrate (GHB) and GABA-B receptors in the acute behavioral effects of GHB in baboons

  2005cited by this paper
• Taurine Interaction with Neurotransmitter Receptors in the CNS: An Update

  2005cited by this paper
• Murine succinate semialdehyde dehydrogenase (SSADH) deficiency, a heritable disorder of GABA metabolism with epileptic phenotype

  2005cited by this paper
• Treatment with and withdrawal from finasteride alter ethanol intake patterns in male C57BL/6J mice: potential role of endogenous neurosteroids?

  2005cited by this paper
• Spontaneous and precipitated withdrawal after chronic intragastric administration of gamma-hydroxybutyrate (GHB) in baboons

  2005cited by this paper
• Resuscitative effect of a gamma-aminobutyric acid B receptor antagonist on gamma-hydroxybutyric acid mortality in mice.

  2005cited by this paper
• Streptozotocin-induced diabetes differentially modifies haloperidol- and γ-hydroxybutyric acid (GHB)-induced catalepsy

  2005cited by this paper
• Inherited disorders of neurotransmitters in children and adults.

  2005cited by this paper
• Photosensitive absence epilepsy with myoclonias and heterozygosity for succinic semialdehyde dehydrogenase (SSADH) deficiency.

  2004cited by this paper
• Presynaptic Modulation of Spontaneous Inhibitory Postsynaptic Currents by Gamma-hydroxybutyrate in the Substantia Nigra Pars Compacta

  2004cited by this paper
• Sedation with 4-hydroxybutyric acid: A potential pitfall in the diagnosis of SSADH deficiency

  2004cited by this paper
• Taurine prevents the neurotoxicity of β‐amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders

  2004cited by this paper
• Seizure evolution and amino acid imbalances in murine succinate semialdehyde dehydrogenase (SSADH) deficiency.

  2004cited by this paper
• Clinical aspects of the disorders of GABA metabolism in children

  2004cited by this paper
• Succinic semialdehyde dehydrogenase deficiency (SSADH) (4-hydroxybutyric aciduria, gamma-hydroxybutyric aciduria).

  2004cited by this paper
• Neurodevelopmental pattern of succinic semialdehyde dehydrogenase deficiency (gamma-hydroxybutyric aciduria).

  2004cited by this paper
• Gamma-hydroxybutyric acid (GHB) and gamma-aminobutyric acidB receptor (GABABR) binding sites are distinctive from one another: molecular evidence.

  2004cited by this paper
• Absence seizures in succinic semialdehyde dehydrogenase deficient mice: a model of juvenile absence epilepsy.

  2004cited by this paper
• The Xyrem® Risk Management Program

  2004cited by this paper
• SGS742: the first GABA(B) receptor antagonist in clinical trials.

  2004cited by this paper
• Gamma-hydroxybutyric acid: neurobiology and toxicology of a recreational drug.

  2004cited by this paper
• γ-Hydroxybutyric acid (GHB) and γ-aminobutyric acidB receptor (GABABR) binding sites are distinctive from one another: molecular evidence

  2004cited by this paper
• γ-Hydroxybutyric Acid

  2004cited by this paper
• Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria).

  2003influential reference
• Magnetic resonance spectroscopy of neurotransmitters in human brain

  2003cited by this paper
• Dextromethorphan alters gene expression in rat brain hippocampus and cortex.

  2003cited by this paper
• GABA(B) receptors as potential therapeutic targets.

  2003influential reference
• Mutational spectrum of the succinate semialdehyde dehydrogenase (ALDH5A1) gene and functional analysis of 27 novel disease‐causing mutations in patients with SSADH deficiency

  2003cited by this paper
• Interactions of taurine and structurally related analogues with the GABAergic system and taurine binding sites of rabbit brain

  2003cited by this paper
• Substrate specificity of mouse aldo-keto reductase AKR7A5.

  2003cited by this paper
• Gamma-hydroxybutyrate reduces mitogen-activated protein kinase phosphorylation via GABA B receptor activation in mouse frontal cortex and hippocampus.

  2003cited by this paper
• γ-Hydroxybutyrate Reduces Mitogen-activated Protein Kinase Phosphorylation via GABAB Receptor Activation in Mouse Frontal Cortex and Hippocampus*

  2003cited by this paper
• Monitoring of 4‐hydroxybutyric acid levels in body fluids during vigabatrin treatment in succinic semialdehyde dehydrogenase deficiency

  2003cited by this paper
• Clinical spectrum of succinic semialdehyde dehydrogenase deficiency

  2003influential reference
• Selective γ‐hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative/hypnotic effect of γ‐hydroxybutyric acid

  2003cited by this paper
• Effect of valproic acid on the urinary metabolic profile of a patient with succinic semialdehyde dehydrogenase deficiency.

  2003cited by this paper
• Murine succinate semialdehyde dehydrogenase deficiency

  2003influential reference
• Vigabatrin and newer interventions in succinic semialdehyde dehydrogenase deficiency

  2003cited by this paper
• Inhibition of succinic semialdehyde dehydrogenase activity by alkenal products of lipid peroxidation.

  2003cited by this paper
• Selective gamma-hydroxybutyric acid receptor ligands increase extracellular glutamate in the hippocampus, but fail to activate G protein and to produce the sedative/hypnotic effect of gamma-hydroxybutyric acid.

  2003cited by this paper
• Oxidative stress and dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease.

  2002cited by this paper
• The peroxisome proliferator-activated receptor alpha-selective activator ciprofibrate upregulates expression of genes encoding fatty acid oxidation and ketogenesis enzymes in rat brain.

  2002cited by this paper
• Therapeutic intervention in mice deficient for succinate semialdehyde dehydrogenase (gamma-hydroxybutyric aciduria).

  2002influential reference
• Neuroprotective actions of selegiline

  2002cited by this paper
• Enzyme and Receptor Antagonists for Preventing Toxicity from the Gamma‐Hydroxybutyric Acid Precursor 1,4‐Butanediol in CD‐1 Mice

  2002cited by this paper
• Focal neurometabolic alterations in mice deficient for succinate semialdehyde dehydrogenase

  2002influential reference
• Gamma-hydroxybutyrate increases tryptophan availability and potentiates serotonin turnover in rat brain.

  2002cited by this paper
• Characterisation of a novel mouse liver aldo‐keto reductase AKR7A5

  2002cited by this paper
• Basic Pharmacology of Valproate

  2002cited by this paper
• Protective effect of melatonin in a chronic experimental model of Parkinson's disease.

  2002influential reference
• Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy.

  2002cited by this paper
• Block of cloned human T-type calcium channels by succinimide antiepileptic drugs.

  2001cited by this paper
• The role of GABAergic neuroactive steroids in ethanol action, tolerance and dependence.

  2001cited by this paper
• Taurine modulates catalase, aldehyde dehydrogenase, and ethanol elimination rates in rat brain.

  2001cited by this paper
• Uridine receptor: discovery and its involvement in sleep mechanism.

  2001cited by this paper
• Pharmacologic rescue of lethal seizures in mice deficient in succinate semialdehyde dehydrogenase

  2001influential reference
• Alterations in cytochrome c oxidase activity and energy metabolites in response to kainic acid-induced status epilepticus.

  2001cited by this paper
• Binding characteristics of the gamma-hydroxybutyric acid receptor antagonist [(3)H](2E)-(5-hydroxy-5,7,8,9-tetrahydro-6H-benzo[a][7]annulen-6-ylidene) ethanoic acid in the rat brain.

  2001cited by this paper
• Superoxide dismutase, glutathione peroxidase activities and the hydroperoxide concentration are modified in the hippocampus of epileptic rats.

  2001cited by this paper
• Binding Characteristics of the γ-Hydroxybutyric Acid Receptor Antagonist [3H](2E)-(5-Hydroxy-5,7,8,9-tetrahydro-6H-benzo[a][7]annulen-6-ylidene) Ethanoic Acid in the Rat Brain

  2001cited by this paper
• gamma-Aminobutyric acid, acting through gamma -aminobutyric acid type A receptors, inhibits the biosynthesis of neurosteroids in the frog hypothalamus.

  2000cited by this paper
• Gamma-hydroxybutyrate, gamma-butyrolactone, and 1,4-butanediol: a case report and review of the literature.

  2000cited by this paper
• Nitric Oxide Can Differentially Modulate Striatal Neurotransmitter Concentrations via Soluble Guanylate Cyclase and Peroxynitrite Formation

  2000cited by this paper

• Sustainable and Integrated Flow-Based Three-Step Synthesis of Sodium Valproate

  2025cites this paper
• Metabolic functions of misunderstood D-2-hydroxyglutarate

  2024cites this paper
• Glioma Cells Expressing High Levels of ALDH5A1 Exhibit Enhanced Migration Transcriptional Signature in Patient Tumors

  2023cites this paper
• ADHD symptoms in neurometabolic diseases: Underlying mechanisms and clinical implications.

  2021cites this paper
• γ-Hydroxybutyric Acid: Pharmacokinetics, Pharmacodynamics, and Toxicology

  2021cites this paper
• Movement Disorders and Inherited Metabolic Disorders

  2020cites this paper
• The suppression of Arabidopsis succinic semialdehyde dehydrogenase (SSADH) phenotype by using ethyl methane-sulfonate mutagenesis (EMS)

  2017cites this paper
• mTOR, Autophagy, Aminoacidopathies, and Human Genetic Disorders

  2016cites this paper
• Correlation of blood biomarkers with age informs pathomechanisms in succinic semialdehyde dehydrogenase deficiency (SSADHD), a disorder of GABA metabolism

  2016cites this paper
• Adrenal cortex expression quantitative trait loci in a German Holstein × Charolais cross

  2016cites this paper
• Single amino acid polymorphism in aldehyde dehydrogenase gene superfamily.

  2015cites this paper
• The GABA transaminase, ABAT, is essential for mitochondrial nucleoside metabolism.

  2015cites this paper
• A QM/MM study of the catalytic mechanism of succinic semialdehyde dehydrogenase from Synechococcus sp. PCC 7002 and Salmonella typhimurium

  2015cites this paper
• Modeling conformational redox‐switch modulation of human succinic semialdehyde dehydrogenase

  2015cites this paper
• Evidence of redox imbalance in a patient with succinic semialdehyde dehydrogenase deficiency

  2014cites this paper
• A Review of Traditional and Novel Treatments for Seizures in Autism Spectrum Disorder: Findings from a Systematic Review and Expert Panel

  2013cites this paper
• Increased Oxidative Metabolism and Neurotransmitter Cycling in the Brain of Mice Lacking the Thyroid Hormone Transporter Slc16a2 (Mct8)

  2013cites this paper
• A novel ALDH5A1 mutation is associated with succinic semialdehyde dehydrogenase deficiency and severe intellectual disability in an Iranian family

  2013cites this paper
• Thirty years beyond discovery—Clinical trials in succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism

  2013cites this paper
• Succinat-Semialdehyd-Dehydrogenase-Mangel: eine vererbbare neurometabolische Erkrankung

  2013cites this paper
• Phenotypic and chemotypic characterization of GABA-shunt mutants in Arabidopsis thaliana

  2013cites this paper
• The child with autism

  2013cites this paper
• Date‐Rape Drugs with Emphasis on GHB

  2012cites this paper
• Approach to the genetic evaluation of the child with autism.

  2012cites this paper
• Genetic inborn error of metabolism provides unique window into molecular mechanisms underlying taurine therapy

  2012cites this paper
• Succinic Semialdehyde Dehydrogenase: Biochemical–Molecular–Clinical Disease Mechanisms, Redox Regulation, and Functional Significance

  2011cites this paper
• Efficacy of vigabatrin intervention in a mild phenotypic expression of succinic semialdehyde dehydrogenase deficiency.

  2011cites this paper
• Identification of succinic semialdehyde reductases from Geobacter: expression, purification, crystallization, preliminary functional, and crystallographic analysis.

  2011cites this paper
• Plasticity of postsynaptic, but not presynaptic, GABAB receptors in SSADH deficient mice.

  2010cites this paper
• Sleep disorders in succinic semialdehyde dehydrogenase deficiency: a family report.

  2010cites this paper
• [Succinic semialdehyde dehydrogenase deficiency: decrease in 4-OH-butyric acid levels with low doses of vigabatrin].

  2010cites this paper
• The X-Ray Crystal Structure of Escherichia coli Succinic Semialdehyde Dehydrogenase; Structural Insights into NADP+/Enzyme Interactions

  2010cites this paper
• Neuropathology in succinic semialdehyde dehydrogenase deficiency.

  2010cites this paper
• γ-Hydroxybutyric acid and its relevance in neurology

  2009cites this paper
• ‘Succinic semialdehyde dehydrogenase deficiency: phenotype evolution in an adolescent patient at 20‐year follow‐up’

  2008cites this paper
• Neuropsychiatric Morbidity in Adolescent and Adult Succinic Semialdehyde Dehydrogenase Deficiency Patients

  2008cites this paper
• 2007 Publications of the Baylor Health Care System Medical and Scientific Staff

  2008cites this paper
• Neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during development

  2008cites this paper
• Pathogenesis of CNS involvement in disorders of amino and organic acid metabolism

  2008cites this paper
• Aldehyde dehydrogenase as a marker for stem cells.

  2008cites this paper
• Qualitative urinary organic acid analysis: Methodological approaches and performance

  2008cites this paper
• SSADH deficiency leads to elevated extracellular GABA levels and increased GABAergic neurotransmission in the mouse cerebral cortex

  2008cites this paper
• Ketogenic diet: stoking energy stores and still posing questions.

  2008cites this paper
• Disorders of Neurotransmission

  2006cites this paper